Table of Contents

2017 Month : October Volume : 6 Issue : 84 Page : 5828-5831

COMPARISON OF HYPERFRACTIONATION AND CONVENTIONAL METHOD OF RADIOTHERAPY IN HEAD AND NECK CANCERS.

Ramkumar Bakthavachalam1, Vidya Albert Yen2

1Assistant Professor, Department of Medical Oncology, Madras Medical College, Chennai.
2Associate Professor, Department of Dental Surgery, Chengalpattu Medical College, Chengalpattu.

References :

1

Nandakumar A, Rath GK, Kataki AC, et al. Survival in head and neck cancers. Results of a multi-institutional study. Asian Pac J Cancer Prev 2016;17(4):1745-54.               

CrossRef | PubMed
2

Saunders MI. Head and neck cancers: altered fractionation schedules. The Oncologist 1999;4(1):11-6.                      

CrossRef | Google Scholar | PubMed
3

Alam MS, Perween R, Siddiqui SA. Comparison of two different radiation fractionation schedules with concurrent chemotherapy in head and neck malignancy. Indian J Cancer 2016;53(2):265-9.               

CrossRef | Google Scholar | PubMed
4

Ang KK. Altered fractionation trials in head and neck cancer. Semin Radiat Oncol 1998;8(4):230-6.          

Google Scholar | PubMed
5

Ang KK. Altered fractionation in the management of head and neck cancer. Int J Radiat Biol 1998;73(4):395-9.           

PubMed
6

Baujat B, Bourhis J, Blanchard P, et al. Hyperfractionated or accelerated radiotherapy for head and neck cancer. Conchrane Database of Systemic Review 2010;(12): CD002026.              

Google Scholar | PubMed
7

Overgaard J, Mohanti BK, Begum N, et al. Five versus six fractions of radiotherapy per week for squamous-cell carcinoma of head and neck(IAEA-ACC Study): a randomised, multicentre trial. Lancet Oncol 2010;11(6):553-60.             

CrossRef | Google Scholar | PubMed
8

Tirkes T, Hollar MA, Tann M, et al. Response criteria in oncologic imaging: review of traditional and new criteria. Radographics 2013;33(5):1323-41.         

CrossRef | Google Scholar | PubMed
9

Withers HR, Taylor JM, Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherpy. Acta Oncol 1988;27(2):131-46. 

Google Scholar | PubMed
10

Fu KK, Pajak TF, Trotti A, et al. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys 2000;48(1):7-16.               

CrossRef | Google Scholar | PubMed
11

Horiot JC, Bontemps P, van den Bogaert W, et al. Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: Results of the EORTC 22851 randomized trial. Radiother Oncol 1997;44(2):111-21.              

CrossRef | Google Scholar | PubMed
12

Overgaard J, Hielm-Hansen M, Johansen LV, et al. Comparison of conventional and split course radiotherapy as primary treatment in carcinoma of the larynx. Acta Oncol 1988;27(2):147-52.              

Google Scholar | PubMed
13

Wilson GD, Mcnally NJ, Dische S, et al. Measurement of cell kinetics in human tumours in vivo using bromodeoxyuridine incorporation and flow cytometry. Br J Cancer 1988;58(4):423-31.   

Google Scholar | PubMed
14

Dobrowsky W, Dobrowsky E, Naude J, et al. Conventional vs accelerated fractionation in head and neck cancer. British Journal of Cancer Supplement 1996;27:S279-81.  

CrossRef | Google Scholar | PubMed
15

Denekamp J, Dasu A, Waites A, et al. Hyperfractionation as an effective way of overcoming radioresistance. Int J Radiat Oncol Biol Phys 1998;42(4):705-9.             

CrossRef | Google Scholar | PubMed
16

Mishra H, Mishra R, Shahi UP, et al. A randomised prospective study of concurrent chemo-radiotherapy vs accelerated hyperfractionation in advanced cancer of head and neck. J Clin Diagn Res 2016;10(10):XC15-XC18.             

CrossRef | Google Scholar | PubMed